LOXL3 and melanoma: This study builds upon our previous data involving LOXL3 in human melanomagenesis, and offers additional distinct and substantial results that warrant the exploration of LOXL3 as a therapeutic target in malignant melanoma, a very aggressive condition in need of improved treatment options.